ondasdechoque.org
PT-BR

Plantar heel pain / plantar fasciopathy · Review · 2025

How does shockwave compare with ultrasound therapy for heel pain?

This review of 13 trials looked mainly at ultrasound therapy for heel pain. In the four trials that compared its effect on pain with shockwave, both alongside stretching, the review did not find a clear difference in pain between the two.

trials
13
people with heel pain
594
trials in the ultrasound-versus-shockwave pain comparison
4

Good to know: This review was mainly about ultrasound therapy; shockwave was one of several comparison treatments.

Li X, Yang J, Li S, et al. Annals of Medicine, 2025 · Read the paper ↗

How this study worked

One answer
A review gathers earlier studies to answer one question. Illustration, not to scale.

What the trials used

Ultrasound protocols reported in included trials
Table 1 reports continuous or pulsed ultrasound, frequencies 1–3 MHz, intensities from 0.5 to 2.0 W/cm² where stated, treatment duration 4–10 minutes where stated, and pulse ratios/duty cycles in some studies. Protocols varied; details were not supplied uniformly.
ESWT active comparator protocols
Across the ESWT comparison rows, reported regimens included 2,000 shocks at 8–10 Hz and 2–2.5 bar, and a regimen printed as 2,000 pulses per session, given as 1,500 shocks at 3 Hz and 0.2 mJ/mm² plus 300 at 8 Hz and 0.3 mJ/mm² (the two listed parts add up to 1,800). Other studies used distinct protocols; no unit conversion is made.
Co-interventions and sham
Inclusion required CPE to include daily stretching of the plantar fascia and calf muscles. Several comparisons added ultrasound or another intervention to CPE. Table 1 lists sham ultrasound in three studies (Katzap, Pandurang, Crawford), which the text counts as CPE-alone or no-treatment comparisons; exact sham details are not consistently given in the review.

Who took part

Thirteen prospective trials/RCTs of patients with plantar fasciitis; the review reports 594 participants overall. The study populations and treatment comparisons varied.

Side effects

The review did not summarise side effects.

All the numbers and the full appraisal
FROM THE FULL PAPER

The results, in numbers.

Thirteen prospective trials/RCTs of patients with plantar fasciitis; the review reports 594 participants overall. The study populations and treatment comparisons varied.

Pain intensity: ultrasound versus no treatment2 reported outcomes
01
After treatment; exact common timepoint not stated in the text

Pain intensity: ultrasound versus no treatment

VAS VAS points

MD-0.79CI -1.84 to 0.27p = 0.14

Ultrasound versus no treatment; lower score favored ultrasound in the article text

2 studies · I²=0%; heterogeneity test p=0.58

-2.1Equal results 00.5

The pooled difference was not statistically significant; the interval includes no difference and does not establish equivalence.

Analysis details and source

The narrative identifies two studies (Cheing et al. 2007, Crawford 1996). Table 1 lists Crawford's comparator as sham ultrasound, although the text counts this study as a no-treatment comparison. VAS scale range and the exact common follow-up are not reported in the text; do not infer them.

04
After treatment; exact common timepoint not stated

Pain intensity: ultrasound plus CPE versus ESWT plus CPE

VAS VAS points

MD0.75CI -0.28 to 1.78p = 0.15

US plus CPE versus ESWT plus CPE; positive values favor ESWT plus CPE (the Results say ESWT showed a higher pain reduction, not statistically significant)

4 studies

-0.5Equal results 02

The interval includes no difference. This does not establish equivalence between ultrasound and ESWT.

Analysis details and source

Four studies compared ESWT plus CPE as comparator. The estimate is reported in the abstract; no participant total or common follow-up is stated there.

VAS and NPRS, as used by different studies1 reported outcome
02
After treatment; study-specific timing not consistently stated

Pain intensity: ultrasound plus CPE versus CPE

VAS and NPRS, as used by different studies Scale points (VAS/NPRS); scale ranges not stated

MD-0.96CI -2.38 to 0.45p = 0.18

Ultrasound plus CPE versus CPE alone; negative values favor ultrasound plus CPE (the Results report a higher pain reduction in the ultrasound plus CPE group)

3 studies · I²=49%; heterogeneity test p=0.14

-2.7Equal results 00.8

The pooled pain difference was not statistically significant (MD −0.96, 95% CI −2.38 to 0.45, p = 0.18); the point estimate favored ultrasound plus CPE, and the authors report no superiority of ultrasound plus CPE over CPE alone. The interval includes no difference and does not establish equivalence.

Analysis details and source

Five studies were in this comparison; three assessed pain (Akınoğlu and Köse and Wu et al. with the VAS, Katzap et al. with the NPRS) and were pooled as a mean difference in Figure 4. Scale ranges and a common follow-up are not stated. Table 1 lists Katzap's comparator as sham ultrasound plus CPE, although the text counts it as CPE alone.

VAS/NPRS, differing across included studies1 reported outcome
03
After treatment; study-specific

Pain intensity: ultrasound plus CPE versus other interventions plus CPE

VAS/NPRS, differing across included studies Scale points; scale ranges not stated

MD0.78CI 0.12 to 1.44p = 0.02

US plus CPE versus other interventions plus CPE; positive values favor the other interventions (the Results report a higher pain reduction in the other-interventions group)

-0.2Equal results 01.6

A statistically significant pooled contrast is reported, and the discussion says dry needling, local steroid injection and laser with CPE had better analgesia than US with CPE; phonophoresis was described as equivalent. The pooled estimate combines different interventions and scales.

Analysis details and source

Do not interpret the broad pooled contrast as a direct estimate for ESWT; the review separately reports the ESWT subgroup below. Study and participant counts for the abstract estimate are not stated there.

Foot function: FFI, ultrasound plus CPE versus other interventions plus CPE1 reported outcome
05
After treatment; exact common timepoint not stated

Foot function: FFI, ultrasound plus CPE versus other interventions plus CPE

Foot Function Index (FFI) FFI points

MD9.2CI 0.77 to 17.63p = 0.03

Ultrasound plus CPE versus other interventions plus CPE; positive values mean a lower FFI score in the other-interventions group, which the Discussion reads as better foot function with those interventions

-2.1Equal results 019.7

The pooled FFI difference was statistically significant (MD 9.20, 95% CI 0.77 to 17.63, p = 0.03). The Results report a lower FFI score in the other-interventions group, and the Discussion says other interventions plus CPE improved foot function on the FFI. The abstract gives no direction for this estimate yet concludes that ultrasound with CPE may improve foot function; the Discussion draws that conclusion from three ultrasound-plus-CPE versus CPE-alone studies analyzed separately.

Analysis details and source

Comparator pools multiple interventions; do not treat this as an ESWT-specific effect.

Hindfoot function: AOFAS, ultrasound plus CPE versus other interventions plus CPE1 reported outcome
06
After treatment; exact common timepoint not stated

Hindfoot function: AOFAS, ultrasound plus CPE versus other interventions plus CPE

American Orthopaedic Foot and Ankle Society (AOFAS) score Score points; range not stated

MD-3.4CI -7.77 to 0.97p = 0.13

Ultrasound plus CPE versus other interventions plus CPE; negative values mean a higher AOFAS score in the other-interventions group, as the Results report

2 studies · I²=0%; heterogeneity test p=0.69

-8.8Equal results 02

The pooled AOFAS difference was not statistically significant (MD −3.40, 95% CI −7.77 to 0.97, p = 0.13); the point estimate showed a higher AOFAS score with the other interventions plus CPE. Nonsignificance does not establish equivalence.

Analysis details and source

The abstract gives no AOFAS estimate; the Results report it for Figure 7, from two studies (Ulusoy et al. 2017, Akinoglu et al. 2017). The comparator group pools more than one intervention, so this is not an ESWT-specific effect; the scale range and a common follow-up are not stated.

How treatment was delivered
Ultrasound protocols reported in included trials

Table 1 reports continuous or pulsed ultrasound, frequencies 1–3 MHz, intensities from 0.5 to 2.0 W/cm² where stated, treatment duration 4–10 minutes where stated, and pulse ratios/duty cycles in some studies. Protocols varied; details were not supplied uniformly.

ESWT active comparator protocols

Across the ESWT comparison rows, reported regimens included 2,000 shocks at 8–10 Hz and 2–2.5 bar, and a regimen printed as 2,000 pulses per session, given as 1,500 shocks at 3 Hz and 0.2 mJ/mm² plus 300 at 8 Hz and 0.3 mJ/mm² (the two listed parts add up to 1,800). Other studies used distinct protocols; no unit conversion is made.

Co-interventions and sham

Inclusion required CPE to include daily stretching of the plantar fascia and calf muscles. Several comparisons added ultrasound or another intervention to CPE. Table 1 lists sham ultrasound in three studies (Katzap, Pandurang, Crawford), which the text counts as CPE-alone or no-treatment comparisons; exact sham details are not consistently given in the review.

HARMS & TOLERABILITY

The review does not provide a systematic adverse-event summary or usable event counts. Absence of reporting cannot be interpreted as zero harms.

LIMITS OF THE ANALYSIS

The authors included 13 studies and note relatively few high-quality trials; variation in pain duration, ultrasound mode/frequency/intensity/pulse ratio/duration and outcome measures limits comparability.

The supplement and primary reports were not acquired for this extraction, so numeric study-level results, follow-up alignment and risk-of-bias judgments could not be independently checked against the trials.

The text reports 13 studies/594 participants but comparison counts overlap because some studies have multiple treatment arms; do not sum subgroup study counts as unique studies or participants.

Findings checked against the full source by a separate automated reviewer.

Limitations noted by the reviewers

  • The authors included 13 studies and note relatively few high-quality trials; variation in pain duration, ultrasound mode/frequency/intensity/pulse ratio/duration and outcome measures limits comparability.
  • The supplement and primary reports were not acquired for this extraction, so numeric study-level results, follow-up alignment and risk-of-bias judgments could not be independently checked against the trials.
  • The text reports 13 studies/594 participants but comparison counts overlap because some studies have multiple treatment arms; do not sum subgroup study counts as unique studies or participants.
Research review

Source-linked critical reading

Systematic review with meta-analysis

Reading depthMaterial consulted
Technical source record

Complete XML body through funding, conflicts and data availability; raw Table 1, figure count/captions for all seven figures, abstract and all outcome discussions read. Supplement and individual trial reports unavailable.

Review statusAI-assisted draft · independent automated checkThis automated check comes before the editor’s clinical review.
Design and evidence base

Systematic review and meta-analysis registered as PROSPERO CRD42024505892. The authors searched through July 2024 and included 13 prospective trials/RCTs with 594 participants. They used RevMan 5.3 and reported mean differences with confidence intervals.

Participants

People diagnosed with plantar fasciitis; studies varied in age, sex, chronicity and intervention. Table 1 shows 13 studies, including multi-arm trials; comparison groups overlap and are not additive.

Ultrasound and comparator protocols

Ultrasound protocols varied between continuous and pulsed delivery, 1–3 MHz, reported intensities 0.5–2.0 W/cm², and 4–10 minute applications where stated. Some reports described pulse ratios or duty cycles. CPE included daily plantar fascia and calf stretching. ESWT comparators varied; Table 1 includes 2,000-shock protocols and distinct energy/frequency schedules. Sham details were limited.

Comparators

Three evidence questions: US versus no treatment; US+CPE versus CPE; and US+CPE versus another intervention+CPE. Some primary trials had three arms, so trial counts across comparisons overlap.

Outcomes

The review evaluates pain by VAS/NPRS and function by FFI/AOFAS. It reports a nonsignificant pain contrast for US versus no treatment (MD −0.79, 95% CI −1.84 to 0.27; p=.14) and for US+CPE versus CPE (MD −0.96, 95% CI −2.38 to 0.45; p=.18). A broader active-intervention contrast favored other treatments for pain; FFI differed, while AOFAS did not. Scale ranges and common follow-up times are not consistently stated.

Between-group findings

For the ESWT subgroup, the abstract reports MD 0.75 (95% CI −0.28 to 1.78; p=.15; four ESWT comparator groups), an inconclusive contrast. It is not evidence of equivalence. The pooled active-treatment pain contrast (MD 0.78, 95% CI 0.12–1.44; p=.02) combines different interventions and scales, so it is not an ESWT-specific result. The FFI estimate is MD 9.20 (95% CI 0.77–17.63; p=.03), with a lower FFI score in the other-interventions group according to the Results, although the abstract concludes that US with CPE may improve foot function.

Harms

No systematic adverse-event results or event counts are reported in the article text. Safety cannot be inferred from nonreporting.

Limitations

The authors cite few high-quality trials and heterogeneity in pain duration, ultrasound parameters and outcome measures. Only the review article was inspected; supplements and primary trials were not acquired. Comparison counts overlap in multi-arm studies.

Applicability

The findings do not support presenting ultrasound as a proven pain treatment or as equivalent to ESWT. Function findings are inconsistent across FFI and AOFAS and remain uncertain.

What stronger evidence needs

Future trials should standardize ultrasound dose and co-care, use transparent sham/comparator methods, prespecify validated pain and function outcomes, report aligned follow-up and harms, and enroll adequate samples.

THE ORIGINAL SOURCE

Read the original article.

The efficacy of ultrasound for plantar fasciitis, a systematic review and meta-analysis.

Li X, Yang J, Li S, Yang L, Meng D. · Annals of medicine · 2025

Open the publication record or available full-text files.

Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →